Loading...

Alexa Fluor® 700 anti-mouse CD45.1 Antibody

Pricing & Availability
Clone
A20 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5.1, LCA
Isotype
Mouse (A.SW) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
A20_Alx700_020608
SJL mouse splenocytes stained with A20 Alexa Fluor® 700
  • A20_Alx700_020608
    SJL mouse splenocytes stained with A20 Alexa Fluor® 700
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
110723 25 µg $101
Check Availability


Need larger quantities of this item?
Request Bulk Quote
110724 100 µg $229
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.1 is an alloantigen of CD45, expressed by Ly5.1 bearing mouse strains (e.g., RIII, SJL/J, STS/A, DA). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in mice that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell types. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
SJL mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD45.1 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633nm / 635nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

The A20 antibody does not react with leukocytes or mouse cells expressing the CD45.2 alloantigen. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation3, in vitro blocking of B cell responses1,2, immunohistochemical staining of frozen sections: OCT embedded7 and acetone-fixed4-6 (direct immunofluorescence detection with fluorochrome conjugated A20 was used in (5) and (6)).

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  4. Suzuki K, et al. 2000. Immunity 13:691. (IHC-F)
  5. Werner N, et al. 2002. Arterioscler. Thromb. Vasc. Biol. 22:1567. (IHC-F)
  6. Lessner SM, et al. 2002. Am. J. Pathol. 160:2145. (FC, IHC-F)
  7. Chen CC, et al. 2005. P. Natl. Acad. Sci. USA 102:11408 (IHC-F)
  8. Pascal V, et al. 2007. J. Immunol. 179:1751. (FC)
  9. Mende I, et al. 2006. Blood 107:1383. (IHC-F, FC)
  10. Phan TG, et al. 2007. Nature Immunol. 8:992. (FC)
  11. Wither DR, et al. 2009. J. Immunol. 183:5079. PubMed
  12. Pascal V, et al.2007. J. Immunol. 179:1751. PubMed
  13. Lee SW, et al. 2009. J. Immunol. 182:6753. PubMed
  14. Takada K, et al. 2009. J. Exp Med. 206:2253. PubMed
  15. Beamer CA, et al. 2007. Am. J. Respir. Cell. Mol. Biol. 37:729. (FC) PubMed
  16. Li LX, et al. 2010. J. Immunol. 184:1728. PubMed
  17. Hosoi A, et al. 2008. Cancer Res. 68:3941. (FC) PubMed
  18. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  19. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Lucca L, et al. 2014. J Immunol. 193:3267. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Soon MSF, et al. 2020. Nat Immunol. 1.984027778. PubMed
  4. Charpentier JC, et al. 2020. Nat Commun. 11:180. PubMed
  5. Withers D, et al. 2009. J Immunol. 183:5079. PubMed
  6. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  7. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  8. Garidou L, et al. 2012. J Virol. 86:7060. PubMed
  9. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  10. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  11. Baldwin SL, et al. 2021. PLoS One. 16:e0247990. PubMed
  12. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  13. Huang W, et al. 2014. J Immunol. 193:2267. PubMed
  14. Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed
  15. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  16. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  17. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  18. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  19. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  20. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  21. Rengarajan S, et al. 2020. Cell Rep Med. :1. PubMed
  22. Zenke S, et al. 2020. Immunity. 52(2):313-327. PubMed
  23. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  24. Baasch S, et al. 2021. Cell. . PubMed
  25. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  26. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  27. Ng SS, et al. 2020. Nat Immunol. 21:1205. PubMed
  28. Tondini E, et al. 2022. NPJ Vaccines. 7:64. PubMed
  29. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  30. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  31. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  32. Zhang J, et al. 2021. Nature. 590:457. PubMed
  33. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  34. Li C, et al. 2018. Cell. 174:285. PubMed
  35. Yabas M, et al. 2011. PLoS One. 6:e26440. PubMed
  36. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  37. Huang W, et al. 2014. J Leukoc Biol. 96:55. PubMed
  38. Sabouri Z, et al. 2016. Nat Commun. 7:13381. PubMed
  39. Senatus L, et al. 2020. JCI Insight. 5:00. PubMed
  40. Hoyer FF, et al. 2020. Immunity. 51(5):899-914.e7.. PubMed
  41. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  42. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  43. Li J, et al. 2021. Cell Rep. 37:110124. PubMed
  44. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  45. Eftychi C et al. 2019. Immunity. 51(2):367-380 . PubMed
  46. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  47. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  48. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  49. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
RRID
AB_493732 (BioLegend Cat. No. 110723)
AB_493733 (BioLegend Cat. No. 110724)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.1 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.1 on UniProt.org
Go To Top Version: 2    Revision Date: 06/27/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account